NSE ScannerOpen the scanner

Mirae Asset Mutual Fund · Equity · Mid Cap · Regular plan

Mirae Asset Midcap Fund - Regular Plan - Growth

₹36.678NAV on 30 Oct 2026Expense ratio 2.03%
29 Oct 2025NAV low 32.87 · high 41.21-3.8%

In plain words

Over 3 years it returned +13.1% a year, against +7.4% for its benchmark index.

Its worst fall from a peak in the last 3 years was -22.9%.

On 3-year return it ranks 18 of 28 funds in Mid Cap.

A monthly SIP over 5 years ended ₹25,588 higher in the direct plan than the regular plan, because of the lower expense ratio.

Past returns, not a promise of future returns or a recommendation.

Returns vs benchmark

PeriodFundBenchmark
1 month-4.0%+1.9%
3 months-8.6%-5.1%
6 months-1.2%-3.2%
1 year-3.8%-10.2%
3 years (yearly)+13.1%+7.4%
5 years (yearly)+12.0%+6.5%
Since start (yearly)+19.8%+11.2%

Monthly SIP of ₹10,000

PeriodInvestedValue nowYearly return
1 year₹1,20,000₹1,16,431-4.8%
3 years₹3,60,000₹3,90,214+5.0%
5 years₹5,90,000₹7,84,762+11.2%

Top holdings (30 Sept 2026)

Fund size ₹19,539 crore · 65 holdings · 97.6% in equity

CompanyIndustryWeight
Laurus Labs Ltd.Pharmaceuticals & Biotechnology4.31%
Steel Authority of India Ltd.Ferrous Metals3.76%
HDB Financial Services Ltd.Finance3.36%
Lupin Ltd.Pharmaceuticals & Biotechnology3.34%
Delhivery Ltd.Transport Services3.01%
Hero MotoCorp Ltd.Automobiles2.89%
Persistent Systems Ltd.IT - Software2.86%
IndusInd Bank Ltd.Banks2.69%
Swiggy Ltd.Retailing2.67%
Dixon Technologies (India) Ltd.Consumer Durables2.66%
Dalmia Bharat Ltd.Cement & Cement Products2.54%
Tata Communications Ltd.Telecom - Services2.52%
Bharat Forge Ltd.Auto Components2.28%
Narayana Hrudayalaya Ltd.Healthcare Services2.13%
Axis Bank Ltd.Banks2.13%

Largest industries: Pharmaceuticals & Biotechnology 11.5%, Banks 8.3%, Consumer Durables 7.8%, Retailing 6.4%, Finance 6.0%, Auto Components 5.3%.

Other plan of this fund: Mirae Asset Midcap Fund - Direct Plan - Growth

Share on WhatsAppShare on Telegram